This trial is a Phase 2 Multicenter, Double-blind, Randomized, Parallel-Group, Vehicle-
Controlled Study to Evaluate the Efficacy, Safety, and Local Tolerability of
G001 in Patients with Osteoarthritis (OA) of the Knee. The objectives of this study are to explore the efficacy, safety, and local tolerability of G001 compared to vehicle in patients with symptomatic osteoarthritis (OA) of the knee.

Trial Information

Start DateFebruary 2021
End DateFebruary 2022
Trial Duration1 year
Number of Visits8 visits
Lead CRCAdam Pawluch
StatusIn recruitment

For additional information
on this trial contact:

Phone705-566-0005